diabetes glp-1 agonist glp-1_analogs [TUSOM New GLP-1 Guidelines for Type
Description
McGlory C, van Vliet S, Stokes T, Mittendorfer B, Phillips SM
The GLP-1 resistance in diabetic conditions is thought to be caused by the downregulation of the GLP-1R caused by PKC overexpression and the decreased GLP-1 post-receptor anti-apoptotic signaling pathways caused by PKC overexpression [83]
This process is crucial for meeting the hearts energy requirements
Hepatic glucose homeostasis during fasting or hypoglycemia depends critically on GCG signaling, which activates both glycogen breakdown and gluconeogenic pathways to prevent dangerous decreases in circulating glucose levels
While pipelines at companies such as Novo Nordisk and Eli Lilly dominate headlines, accelerating demand and supply chain constraints are shifting attention toward the wider ecosystem required to scale production
April 12, 2025
